Literature DB >> 2153233

Simian virus 40 large T antigen induces or activates a protein kinase which phosphorylates the transformation-associated protein p53.

K H Scheidtmann1, A Haber.   

Abstract

The cellular phosphoprotein p53 is presumably involved in simian virus 40 (SV40)-induced transformation. We have monitored changes in the state of phosphorylation of p53 from normal versus SV40-infected or -transformed cells. In normal cells, p 53 was hardly phosphorylated. Upon infection or transformation, a quantitative and qualitative increase in p53 phosphorylation was observed as revealed by two-dimensional phosphopeptide analysis. This increase was dependent on a functional large T antigen. In rat cells, enhanced phosphorylation of p53 resulted in conversion to a second, electrophoretically distinct form. In cells transformed with transformation-defective mutants, phosphorylation of p53 was reduced and conversion to form 2 was inefficient. These data suggest (i) that SV40 large T antigen induces or activates a protein kinase, one substrate of which is p53, (ii) that transformation-defective mutants are impaired in kinase induction, and (iii) that either a certain phosphorylation state of p53 or the SV40-induced kinase is critical for efficient transformation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2153233      PMCID: PMC249159     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  When the products of oncogenes and anti-oncogenes meet.

Authors:  M R Green
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  The p53 proto-oncogene can act as a suppressor of transformation.

Authors:  C A Finlay; P W Hinds; A J Levine
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

3.  SV40 large T antigen induces a protein kinase responsible for phosphorylation of the cellular protein p53.

Authors:  K H Scheidtmann
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

4.  A short-lived nuclear phosphoprotein encoded by the human ets-2 proto-oncogene is stabilized by activation of protein kinase C.

Authors:  S Fujiwara; R J Fisher; N K Bhat; S M Diaz de la Espina; T S Papas
Journal:  Mol Cell Biol       Date:  1988-11       Impact factor: 4.272

5.  trans-activation of RNA polymerase II and III promoters by SV40 small t antigen.

Authors:  M Loeken; I Bikel; D M Livingston; J Brady
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

6.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene.

Authors:  J A DeCaprio; J W Ludlow; J Figge; J Y Shew; C M Huang; W H Lee; E Marsilio; E Paucha; D M Livingston
Journal:  Cell       Date:  1988-07-15       Impact factor: 41.582

7.  Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB.

Authors:  K K Yamamoto; G A Gonzalez; W H Biggs; M R Montminy
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

8.  A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.

Authors:  E Moran
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

9.  Participation of p53 cellular tumour antigen in transformation of normal embryonic cells.

Authors:  D Eliyahu; A Raz; P Gruss; D Givol; M Oren
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

10.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

View more
  19 in total

Review 1.  Nuclear protein phosphorylation and growth control.

Authors:  D W Meek; A J Street
Journal:  Biochem J       Date:  1992-10-01       Impact factor: 3.857

Review 2.  Protein phosphatases and DNA tumor viruses: transformation through the back door?

Authors:  M C Mumby; G Walter
Journal:  Cell Regul       Date:  1991-08

3.  Simian virus 40 can overcome the antiproliferative effect of wild-type p53 in the absence of stable large T antigen-p53 binding.

Authors:  D Michael-Michalovitz; F Yehiely; E Gottlieb; M Oren
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

4.  Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen.

Authors:  E H Leung; P C Leung; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

5.  Phenotype-specific phosphorylation of simian virus 40 tsA mutant large T antigens in tsA N-type and A-type transformants.

Authors:  U Knippschild; J Kiefer; T Patschinsky; W Deppert
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

6.  Immunochemical characterization of the gap junction protein connexin45 in mouse kidney and transfected human HeLa cells.

Authors:  A Butterweck; U Gergs; C Elfgang; K Willecke; O Traub
Journal:  J Membr Biol       Date:  1994-09       Impact factor: 1.843

7.  Dephosphorylation of simian virus 40 large-T antigen and p53 protein by protein phosphatase 2A: inhibition by small-t antigen.

Authors:  K H Scheidtmann; M C Mumby; K Rundell; G Walter
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

8.  Characterization of human vascular smooth muscle cells transformed by the early genetic region of SV40 virus.

Authors:  A Legrand; P Greenspan; M L Nagpal; S A Nachtigal; M Nachtigal
Journal:  Am J Pathol       Date:  1991-09       Impact factor: 4.307

9.  Human DNA-activated protein kinase phosphorylates serines 15 and 37 in the amino-terminal transactivation domain of human p53.

Authors:  S P Lees-Miller; K Sakaguchi; S J Ullrich; E Appella; C W Anderson
Journal:  Mol Cell Biol       Date:  1992-11       Impact factor: 4.272

10.  Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences.

Authors:  F Tiemann; W Deppert
Journal:  J Virol       Date:  1994-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.